The Desai Sethi Urology Institute (DSUI) is proud to present a new series of interactive Zoom webinars designed to advance knowledge, share clinical insights, and foster collaboration in the field of urology and beyond. These sessions are thoughtfully curated to support ongoing professional development and are eligible for Continuing Medical Education (CME) credits.
Each webinar will feature leading experts discussing current trends, best practices, and emerging research across a range of specialized topics. Attendees will have the opportunity to engage in live Q&A sessions, case discussions, and receive practical takeaways to enhance patient care.
Whether you're a practicing clinician, researcher, or healthcare professional, we invite you to join us for this dynamic series and stay at the forefront of innovation in urology.
This lecture will evaluate updates and outcomes in use of therapeutics at time of RCC surgery
This lecture will explore the evolution of kidney cancer care, highlighting advances in surgery, imaging, and systemic therapy, along with the growing improvement and impact of molecular biology and genetics on patient care.
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to record attendance and receive CME credits, our team will email a unique Claim Credit Link to you after each session.
For any questions please contact: Emma-Hill OToole ehotoole@miami.edu.
The University of Miami adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
